STATE STREET CORP - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 142 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 5.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$18,490,000
+11.5%
1,650,696
+9.5%
0.00%
+100.0%
Q2 2017$16,590,000
+7.6%
1,508,053
-4.1%
0.00%0.0%
Q1 2017$15,423,000
-0.4%
1,573,265
+9.8%
0.00%0.0%
Q4 2016$15,482,000
+3.9%
1,433,388
-1.4%
0.00%
-50.0%
Q3 2016$14,901,000
-9.0%
1,454,110
+16.0%
0.00%0.0%
Q2 2016$16,373,000
+50.7%
1,253,599
+27.0%
0.00%
+100.0%
Q1 2016$10,864,000
+9.8%
987,384
-8.2%
0.00%0.0%
Q4 2015$9,892,000
-29.0%
1,075,097
-46.4%
0.00%
-50.0%
Q3 2015$13,926,000
-23.3%
2,006,869
+8.6%
0.00%0.0%
Q2 2015$18,148,000
+120.9%
1,848,037
+99.4%
0.00%
+100.0%
Q1 2015$8,214,000
+3.0%
926,885
+1.9%
0.00%0.0%
Q4 2014$7,974,000
+13.9%
909,608
-10.5%
0.00%0.0%
Q3 2014$7,003,000
+36.3%
1,016,218
+4.1%
0.00%0.0%
Q2 2014$5,137,000
+13.6%
975,775
-1.8%
0.00%0.0%
Q1 2014$4,522,000
-53.2%
993,597
-52.1%
0.00%0.0%
Q4 2013$9,661,000
+85.5%
2,072,863
+102.0%
0.00%0.0%
Q3 2013$5,207,000
+1.3%
1,026,364
-0.9%
0.00%0.0%
Q2 2013$5,138,0001,036,1380.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,663,281$16,300,0009.19%
Nantahala Capital Management 1,891,328$18,535,0002.06%
Nine Chapters Capital Management LLC 40,700$399,0000.54%
MENTA CAPITAL LLC 396,336$3,884,0000.38%
Sapphire Star Partners LP 30,439$298,0000.34%
TFS CAPITAL LLC 95,432$935,0000.30%
Ativo Capital Management LLC 123,428$1,210,0000.30%
GLG Partners LP 363,188$3,559,0000.17%
GSA CAPITAL PARTNERS LLP 240,013$2,352,0000.13%
Bowling Portfolio Management LLC 68,473$671,0000.11%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders